Esperanza Feijoo Blanco

Esperanza Feijoo Blanco is a Researcher at the Cancer Center of the University of Navarra, Spain, affiliated with the AAV4Cancer research group specializing in Advanced Therapies for Rare Liver Diseases.

She earned her Doctorate from Universidad Complutense de Madrid in 1995 with thesis research on "Inmunocomplejos circulantes y mecanismos autoinmunes en la infección por el Virus de la Inmunodeficiencia Humana" (Circulating immune complexes and autoimmune mechanisms in Human Immunodeficiency Virus infection), supervised by Dr. Rosa García Delgado.

Her research integrates Cancer Research, Gene Therapy, and Immunology to develop novel treatments for rare hepatic conditions, utilizing adeno-associated virus (AAV) vector technologies. This work bridges virology, hepatology, and advanced therapeutic design for oncological applications.

Dr. Feijoo Blanco actively supervises academic theses as indicated in her profile navigation. Her laboratory work centers on the AAV4Cancer group's mission to pioneer viral vector-based interventions for liver-related cancers and rare diseases.